Press Announcements > FDA approves first generic Strattera for the treatment of ADHD

Press Announcements > FDA approves first generic Strattera for the treatment of ADHD

FDA approves first generic Strattera for the treatment of ADHD

05/30/2017 04:49 PM EDT

The U.S. Food and Drug Administration today approved the first generic versions of Strattera (atomoxetine) to treat attention-deficit/hyperactivity disorder (ADHD) in pediatric and adult patients.